CIK 0000882291
- Non-accelerated filer
- Smaller reporting company
AETHLON MEDICAL INC
Sign in to watch- Ticker
- AEMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133632859
- Phone
- +1 619-941-0360
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121
- Former names
- BISHOP EQUITIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-07-01 | KENLEY RODNEY S President | Grant or award · Stock options (right to buy) | +500,000 | 1,500,000 | ||
| 2013-07-01 | Joyce James A Chairman, CEO, Secretary | Grant or award · Stock Options (right to buy) | +2,000,000 | 14,088,243 | ||
| 2013-07-01 | FRAKES JAMES B Chief Financial Officer | Grant or award · Stock options (right to buy) | +500,000 | 1,000,000 | ||
| 2012-07-24 | BARRY FRANKLYN S JR Director | Grant or award · Stock options (right to buy) | +460,526 | 1,725,076 | ||
| 2012-07-24 | BROENNIMAN EDWARD G Director | Grant or award · Stock options (right to buy) | +460,526 | 1,869,251 | ||
| 2012-06-26 | Joyce James A Chairman, CEO, Secretary | Other disposition | −600,000 | $0.08 | $48K | 3,800,000 |
| 2010-09-27 | Joyce James A Chairman, Pres, CEO, Secy | Grant or award · Stock options (right to buy) | +2,500,000 | 12,088,243 | ||
| 2010-09-27 | BROENNIMAN EDWARD G Director | Grant or award · Stock options (right to buy) | +600,000 | 1,414,225 | ||
| 2010-09-27 | BARRY FRANKLYN S JR Director | Grant or award · Stock Options (right to buy) | +500,000 | 1,266,417 | ||
| 2010-09-27 | Tullis Richard VP, Chief Science Officer | Grant or award · Stock Options (right to buy) | +1,000,000 | 2,897,175 | ||
| 2010-06-30 | Joyce James A Chairman, Pres, CEO, CFO, Secy | Grant or award | +4,000,000 | 4,400,000 | ||
| 2010-04-13 | BROENNIMAN EDWARD G Director | Sale | −4,900 | $0.34 | $2K | 282,174 |
| 2010-04-12 | BROENNIMAN EDWARD G Director | Sale | −12,500 | $0.34 | $4K | 287,074 |
| 2010-04-09 | BROENNIMAN EDWARD G Director | Sale | −12,500 | $0.33 | $4K | 299,574 |
| 2010-04-08 | BROENNIMAN EDWARD G Director | Sale | −12,500 | $0.34 | $4K | 312,074 |
| 2010-04-07 | BROENNIMAN EDWARD G Director | Sale | −12,000 | $0.35 | $4K | 324,574 |
| 2010-04-07 | BARRY FRANKLYN S JR Director | Sale | −4,400 | $0.35 | $2K | 106,593 |
| 2010-04-06 | BROENNIMAN EDWARD G Director | Sale | −11,900 | $0.35 | $4K | 336,574 |
| 2010-04-06 | BARRY FRANKLYN S JR Director | Sale | −11,900 | $0.35 | $4K | 110,993 |
| 2010-04-05 | BROENNIMAN EDWARD G Director | Sale | −11,500 | $0.35 | $4K | 348,474 |
Page 15 of 18 · 360 trades